 Pfizer Inc is forging ahead in its quest to sell an overthecounter version of blockbuster cholesterol pill Lipitor hoping to overcome skepticism that consumers can take the drug appropriately without doctor guidance New uncertainty surrounds Pfizers prospects because of recent changes in clinical guidelines for treating people with cholesterollowering statin drugs such as Lipitor The recommendations eschew familiar and relatively easytounderstand targets for cholesterol levels in favor of a more complex assessment
  